Condition: Chronic Migraine · High Frequency Episodic Migraine · Sponsor: Salvia BioElectronics
The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Genesis Research Services | Broadmeadow, New South Wales, Australia | Active Not Recruiting |
| Resolve Pain | Buderim, Queensland, Australia | Active Not Recruiting |
| ZAS Antwerpen, Campus Sint-Augustinus | Wilrijk, Antwerpen, Belgium | Recruiting |
| Jessa Hasselt | Hasselt, Limburg, Belgium | Recruiting |
| Private Practice Dr. Sava | Saint-Nicolas, Liège, Belgium | Active Not Recruiting |
| AZ Sint Jan Brugge | Bruges, West Vlaanderen, Belgium | Recruiting |
| AZ Groeninge | Kortrijk, West Vlaanderen, Belgium | Recruiting |
| AZ Oostende | Ostend, West Vlaanderen, Belgium | Recruiting |
| AZ Delta | Roeselare, West Vlaanderen, Belgium | Recruiting |
| St. Antonius Nieuwegein | Nieuwegein, Netherlands | Recruiting |
| Erasmus MC Rotterdam | Rotterdam, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06450444